The store will not work correctly when cookies are disabled.
3-(4-(thiophen-2-yl)phenyl)-1-(pyrrolidin-1-yl)propan-1-one
ID: ALA4463773
PubChem CID: 155529982
Max Phase: Preclinical
Molecular Formula: C17H19NOS
Molecular Weight: 285.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CCc1ccc(-c2cccs2)cc1)N1CCCC1
Standard InChI: InChI=1S/C17H19NOS/c19-17(18-11-1-2-12-18)10-7-14-5-8-15(9-6-14)16-4-3-13-20-16/h3-6,8-9,13H,1-2,7,10-12H2
Standard InChI Key: BHZCEFAELXMJBU-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
18.3581 -13.8386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6504 -13.4300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9427 -13.8386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2350 -13.4300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5273 -13.8386 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2350 -12.6128 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7773 -13.5047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2305 -14.1120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6391 -14.8197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4384 -14.6497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3552 -14.6569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0620 -15.0654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7707 -14.6567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7681 -13.8353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0606 -13.4305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4830 -15.0597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5695 -15.8723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3691 -16.0412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7768 -15.3328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2291 -14.7264 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
4 6 2 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 5 1 0
1 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 1 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 16 1 0
13 16 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 285.41 | Molecular Weight (Monoisotopic): 285.1187 | AlogP: 3.97 | #Rotatable Bonds: 4 |
Polar Surface Area: 20.31 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.53 | CX LogD: 3.53 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.83 | Np Likeness Score: -1.40 |
References
1. Zhou P, Xiang L, Zhao D, Ren J, Qiu Y, Li Y.. (2019) Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors., 10 (2): [PMID:30931090] [10.1039/C8MD00432C] |